| __timestamp | Alpine Immune Sciences, Inc. | Apellis Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12199547 | 8379522 |
| Thursday, January 1, 2015 | 16054000 | 13730311 |
| Friday, January 1, 2016 | 23316000 | 22978599 |
| Sunday, January 1, 2017 | 10626000 | 40303878 |
| Monday, January 1, 2018 | 28970000 | 105285576 |
| Tuesday, January 1, 2019 | 35847000 | 220968770 |
| Wednesday, January 1, 2020 | 27185000 | 299921000 |
| Friday, January 1, 2021 | 58742000 | 420869000 |
| Saturday, January 1, 2022 | 70243000 | 387236000 |
| Sunday, January 1, 2023 | 80904000 | 354387000 |
Unveiling the hidden dimensions of data
In the competitive world of biotechnology, research and development (R&D) investments are crucial for driving innovation and maintaining a competitive edge. Over the past decade, Alpine Immune Sciences, Inc. and Apellis Pharmaceuticals, Inc. have demonstrated significant commitment to R&D, with Apellis consistently outspending Alpine.
From 2014 to 2023, Apellis Pharmaceuticals increased its R&D spending by over 4,000%, peaking in 2021 with an investment of approximately $421 million. In contrast, Alpine Immune Sciences showed a steady growth, with a notable 560% increase in R&D expenses, reaching around $81 million in 2023.
This trend highlights the growing emphasis on innovation in the biotech sector, with companies like Apellis and Alpine leading the charge. As these investments continue to rise, the potential for groundbreaking treatments and therapies becomes ever more promising.
Comparing Innovation Spending: BeiGene, Ltd. and Alpine Immune Sciences, Inc.
Research and Development Investment: Genmab A/S vs Alpine Immune Sciences, Inc.
R&D Insights: How Intra-Cellular Therapies, Inc. and Alpine Immune Sciences, Inc. Allocate Funds
Research and Development Expenses Breakdown: Bio-Techne Corporation vs Alpine Immune Sciences, Inc.
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Alpine Immune Sciences, Inc.
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and HUTCHMED (China) Limited
Research and Development Investment: Alpine Immune Sciences, Inc. vs ImmunityBio, Inc.
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and Supernus Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Galapagos NV
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Xencor, Inc.
R&D Spending Showdown: Alpine Immune Sciences, Inc. vs Novavax, Inc.
Research and Development: Comparing Key Metrics for Verona Pharma plc and Apellis Pharmaceuticals, Inc.